Veterinary Medicines

LidoBel, 20mg/ml, Solution for injection

Authorised
  • Lidocaine hydrochloride
Download as PDF

Product identification

Medicine name:
LidoBel, 20mg/ml, Solution for injection
Lidobel vet. 16 mg/ml injektioneste, liuos hevosille, koirille ja kissoille
Active substance:
  • Lidocaine hydrochloride
Target species:
  • Horse
  • Dog
  • Cat
Route of administration:
  • Perineural use
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Lidocaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Perineural use
    • Horse
      • Milk
        5
        day
      • Meat and offal
        5
        day
    • Dog
    • Cat
  • Intramuscular use
    • Horse
      • Milk
        5
        day
      • Meat and offal
        5
        day
    • Dog
    • Cat
  • Subcutaneous use
    • Horse
      • Milk
        5
        day
      • Meat and offal
        5
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • Glass Vial 12 x 250.0 millilitre(s)
  • Glass Vial 1 x 250.0 millilitre(s)
  • Glass Vial 12 x 100.0 millilitre(s)
  • Glass Vial 1 x 100.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 35289
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0140/001
Concerned member states:
  • Austria
  • Belgium
  • Estonia
  • Finland
  • Hungary
  • Iceland
  • Ireland
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."